Billionaires Drive Biotech's Race for Cancer Blockbusters
Just read "For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug" a good book about developing of a pair of cancer drugs. Great work by @nathanvardi https://t.co/rrTOe6GqIB
Mercury's Economist Ad Marks Major Brand Evolution
So cool to stumble on to a @mercury ad in the economist. How far they have come. Well done team. https://t.co/9G8BxxAo7q
US Blocks Iran Oil to China, Marking Escalation
The US is now effectively blockading China’s oil supplies from Iran. This is a nontrivial escalation.
Streetwise Offers Insight, but Skips Goldman’s GFC Leadership
Reading @lloydblankfein’s book streetwise. Sadly he doesn’t really get into the fascinating details of his leadership of goldman during the gfc, but it’s worth a read. I wish he could have written a candid account. https://t.co/78W9nD3ops
Citizens Fill Journalism Gap as SF Chronicle Turns Biased
Crazy that in SF private citizens like @terronk have to do the leg work of journalists as the @sfchronicle is too busy cosplaying as the Pravda for our local progressive confirmation bias...
OpenAI’s Ad Flop Reveals Widespread Misunderstanding of Advertising
It appears Openai is failing badly in ads. The key problem is everyone thinks they understand ads as we all deal with them constantly. As someone who has spent two decades in the space, I can confirm...
Office Return Gains: Downtown 53%, Class A+ 80%
SF Office update from my buddy Jay at Cushman: A slight uptick on back-to-the-office data. Cell phone pings downtown are roughly 53% of where they were in early 2020. Data from Class A+ buildings is 80%.